COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,624 Articles (22,913 medRxiv, 8,711 bioRxiv)

Most recent first Previous |  Page 165: Articles 1641-1650  | Next

Longitudinal cellular and humoral immune responses following Covid-19 BNT162b2-mRNA-based booster vaccination of craft and manual workers in Qatar.
Thomas, R., Zaqout, A., Meqbel, B., Jafar, U., Vaikath, N., Aldushain, A., Naik, A., Shaath, H., Al-Akl, N. S., Adam, A., Ali Moussa, H. Y., Shin, K. C., Taha, R. Z., Abukhattab, M., Almaslamani, M. A., Alajez, N. M., Arredouani, A., Park, Y., Abdulla, S. A., El-Agnaf, O. M., Omrani, A. S., Decock, J.
10.1101/2024.12.10.627725 — Posted: 2024-12-10
Accelerated amyloid deposition in SARS-CoV-2 infected mouse models of Alzheimer's disease
Parekh, P. A., Badachhape, A. A., Redd, J. R., Bonilla, L. J., Bhandari, P., Kneubehl, A. R., Bhavane, R., Clinton, J. L. S., Admane, P., Menon, R., Srivastava, M., Sun, X., Narang, S., Tanifum, E., Ghaghada, K. B., Ronca, S. E., Annapragada, A. V.
10.1101/2024.12.09.627570 — Posted: 2024-12-10
The SARS-CoV-2 envelope PDZ Binding Motif acts as a virulence factor disrupting host's epithelial cell-cell junctions
Alvarez, F., Melo, G. D. d., Larrous, F., Kergoat, L., Boeda, B., Michel, V., Seilhean, D., Tichit, M., Hing, D., Hardy, D., Kornobis, E., Bourhy, H., Wolff, N., Caillet-Saguy, C.
10.1101/2024.12.10.627528 — Posted: 2024-12-10
SARITA: A Large Language Model for Generating the S1 Subunit of the SARS-CoV-2 Spike Protein
Rancati, S., Nicora, G., Bergomi, L., Buonocore, T. M., Czyz, D. M., Parimbelli, E., Bellazzi, R., Salemi, M., Prosperi, M., Marini, S.
10.1101/2024.12.10.627777 — Posted: 2024-12-10
HIPSTR: highest independent posterior subtree reconstruction in TreeAnnotator X
Baele, G., Carvalho, L. M., Brusselmans, M., Dudas, G., Ji, X., McCrone, J. T., Lemey, P., Suchard, M. A., Rambaut, A.
10.1101/2024.12.08.627395 — Posted: 2024-12-10
Orchestration of SARS-CoV-2 Nsp4 and host-cell ESCRT proteins induces morphological changes of the endoplasmic reticulum
Kifer, A., Pina, F., Codallos, N., Hermann, A., Ziegler, L., Niwa, M.
10.1101/2024.12.08.627411 — Posted: 2024-12-10
Comprehensive Analysis of SARS-CoV-2 Spike Evolution: Epitope Classification and Immune Escape Prediction
Teruel, N. F. B., Crown, M., Rajsbaum, R., Bashton, M., Najmanovich, R.
10.1101/2024.12.06.627164 — Posted: 2024-12-09
Defining a highly conserved B cell epitope in the receptor binding motif of SARS-CoV-2 spike glycoprotein
Malladi, S. K., Jaiswal, D., Ying, B., Alsoussi, W., Darling, T., Dadonaite, B., Civljak, A., Horvath, S., Zhou, J., Kim, W., Turner, J., Schmitz, A., Han, F., Scheaffer, S., Farnsworth, C., Nachbagauer, R., Nestorova, B., Chalkias, S., Klebert, M., Edwards, D., Paris, R., Strnad, B., Middleton, W., OHalloran, J., Presti, R., Bloom, J. D., Boon, A. C. M., Diamond, M. S., Bajic, G., Ellebedy, A. H.
10.1101/2024.12.06.625234 — Posted: 2024-12-09
Cost-utility analysis of COVID-19 vaccination strategies for endemic SARS-CoV-2 circulation in Canada
Miranda, R. N., Simmons, A. E., Li, M. W. Z., Gebretekle, G. B., Xi, M., Salvadori, M. I., Warshawsky, B., Wong, E., Ximenes, R., Andrew, M. K., Sander, B., Singh, D., Wilson, S., Tunis, M., Tuite, A. R.
10.1101/2024.12.06.24318620 — Posted: 2024-12-08
Effect of background therapy with Non-steroidal anti-inflammatory drugs (NSAIDs) and other anti-inflammatory agents on COVID-19 outcomes
Miele, L., Chu, S., Hillegass, W., Jurkovitz, C., Beasley, W., Chen, D., Anzalone, J., Fort, D., Kirwan, J., Melancon, B., Hodder, S., Horswell, R.
10.1101/2024.12.07.24318645 — Posted: 2024-12-08

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).